Trader consensus reflects a 95.6% implied probability of no new coronavirus pandemic in 2026, driven by sustained moderate global risk assessments from the WHO as of mid-2026, widespread population immunity from prior SARS-CoV-2 infections and vaccinations, and circulation of known Omicron sublineages such as XFG and BA.3.2 without substantial rises in severity or transmissibility. Official CDC and WHO surveillance shows continued but contained activity, with variants under monitoring exhibiting immune escape yet limited fitness advantages that prevent dominance or overwhelming healthcare systems. Historical patterns of seasonal respiratory virus circulation and declining hospitalization trends further support this positioning. Realistic scenarios that could shift outcomes include undetected emergence of a highly divergent novel coronavirus with enhanced virulence or a significant animal-to-human spillover event not captured by current genomic monitoring.